Reconciling the effects of screening on prostate cancer mortality in the ERSPC and PLCO trials, Ann Intern Med, vol.167, pp.449-55, 2017. ,
Combined analysis of survivin autoantibody and carcinoembryonic antigen biomarkers for improved detection of colorectal cancer, Clin Chem Lab Med, vol.48, pp.719-744, 2010. ,
Current noninvasive tests for colorectal cancer screening: an overview of colorectal cancer screening tests, World J Gastrointest Oncol, vol.8, pp.793-800, 2016. ,
Fecal DNA testing for colorectal cancer screening: molecular targets and perspectives, World J Gastrointest Oncol, vol.7, pp.178-83, 2015. ,
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population, N Engl J Med, vol.351, pp.2704-2718, 2004. ,
Multitarget stool DNA testing for colorectal-cancer screening, N Engl J Med, vol.370, pp.1287-97, 2014. ,
, NCI dictionary of cancer terms Natl Cancer Inst nd
Les acides nucléiques du plasma sanguin chez l'homme, CR Seances Soc Biol Fil, vol.142, pp.241-244, 1948. ,
Isolation and characterization of DNA from the plasma of cancer patients, Eur J Cancer Clin Oncol, vol.23, pp.707-719, 1987. ,
Origins, structures, and functions of circulating DNA in oncology, Cancer Metastasis Rev, vol.35, pp.347-76, 2016. ,
Current challenges for detection of ,
Screening tests: a review with examples, Inhal Toxicol, vol.26, pp.811-839, 2014. ,
Principles and practice of screening for disease, Geneva : World Health Organisation, vol.164, 1968. ,
Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years, Bull World Health Organ, vol.86, pp.317-336, 2008. ,
Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation, Casp J Intern Med, vol.4, pp.627-662, 2013. ,
Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer, N Engl J Med, vol.357, pp.1579-88, 2007. ,
Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer: a retrospective analysis of kinetics on 743 breast cancer patients, Clin Chim Acta, vol.448, pp.228-259, 2015. ,
Measurement of prostate-specific antigen in serum as a screening test for prostate cancer, N Engl J Med, vol.324, pp.1156-61, 1991. ,
Mortality results from a randomized prostate-cancer screening trial, N Engl J Med, vol.360, pp.1310-1329, 2009. ,
Screening and prostate-cancer mortality in a randomized European study, N Engl J Med, vol.360, pp.1320-1348, 2009. ,
Direct detection of early-stage cancers using circulating tumor DNA, Sci Transl Med, vol.9, p.2415, 2017. ,
Identification of circulating tumor DNA for the early detection of small-cell lung cancer, EBioMedicine, vol.10, pp.117-140, 2016. ,
Detection and localization of surgically resectable cancers with a multi-analyte blood test, Science, p.3247, 2018. ,
Analysis of plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer, N Engl J Med, vol.377, pp.513-535, 2017. ,
High fragmentation characterizes tumour-derived circulating DNA, PLoS One, vol.6, 2011. ,
Increased DNA integrity in colorectal cancer, In Vivo (Brooklyn), vol.28, pp.299-303, 2014. ,
Methods for screening a subject for cancer ,
Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients, Clin Transl Oncol, pp.1-6, 2017. ,
The prostate health index: a new test for the detection of prostate cancer, Ther Adv Urol, vol.6, pp.74-81, 2014. ,
Dépister les cancers asymptotiques ?, Med Sci, vol.34, pp.363-368, 2018. ,
Clinical significance of folate receptor-positive circulating tumor cells detected by ligand-targeted polymerase chain reaction in lung cancer, J Cancer, vol.8, pp.104-114, 2017. ,
Liquid biopsies: genotyping circulating tumor DNA, J Clin Oncol, vol.32, pp.579-86, 2014. ,
Circulating tumor DNA outperforms circulating tumor cells for KRAS mutation detection in thoracic malignancies, Clin Chem, vol.61, pp.1299-304, 2015. ,
Characterization of single circulating tumor cells, FEBS Lett, vol.591, pp.2241-50, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01762116
Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer, Breast Cancer Res, vol.12, p.90, 2010. ,
Novel circulating microRNA signature as a potential noninvasive multi-marker test in ER-positive early-stage breast cancer: a case control study, Mol Oncol, vol.8, pp.874-83, 2014. ,
Circulating epigenetic biomarkers in lung malignancies: from early diagnosis to therapy, Lung Cancer, vol.107, pp.65-72, 2017. ,
Circulating cancer-associated macrophage-like cells differentiate malignant breast cancer and benign breast conditions, Cancer Epidemiol Prev Biomarkers, vol.25, pp.1037-1079, 2016. ,
Plasma biomarker profiles differ depending on breast cancer subtype but RANTES is consistently increased, Cancer Epidemiol Biomarkers Prev, vol.20, pp.1543-51, 2011. ,
Platelet RNA signatures for the detection of cancer, Cancer Metastasis Rev, pp.1-10, 2017. ,